Literature DB >> 29021108

Effects of a multifaceted implementation intervention to increase utilization of pharmacological treatments for alcohol use disorders in the US Veterans Health Administration.

Alex H S Harris1, Randall Brown2, Michael Dawes3, Eric Dieperink4, Donald Hugh Myrick5, Heather Gerould6, Todd H Wagner7, Jennifer P Wisdom8, Hildi J Hagedorn9.   

Abstract

Over 16 million Americans meet diagnostic criteria for alcohol use disorder (AUD), but only 7.8% of them receive formal treatment each year. Safe and effective pharmacological treatments for AUD exist; however, they are rarely prescribed. Therefore, we developed and pilot tested a multifaceted implementation intervention to improve consideration and receipt of effective pharmacologic treatments for AUD, focusing on primary care settings where patients have the most frequent contact with healthcare systems. The intervention included training of local providers to serve as champions and a website for primary care providers that included educational materials, a case-finding dashboard, and contact information for local and national clinical experts. We also mailed patients educational material about treatment options. The intervention was implemented at three large facilities of the Veterans Health Administration (VHA). An interrupted time series design, analyzed with segmented logistic regression, was used to evaluate the intervention's effects. The odds of a patient with AUD receiving one of the AUD medications was increasing throughout the pre-implementation period, and the rate of change (slope) increased significantly in the implementation period. Translating these numbers into percentages, at baseline 2.9% of patients filled a prescription for an AUD medication within 30days of a primary care visit. This increased to 3.8% by the end of the pre-implementation period (increasing 0.037% per month), and increased to 5.2% by the end of the implementation period (increasing 0.142% per month). However, the intervention effect was not significant when control sites were added, suggesting that improvement may have been driven by secular trends rather than solely by this intervention. Although the intervention was feasible, it was not effective. Continued analysis of process and implementation data including qualitative interviews with key stakeholders, may elucidate the reasons this intervention was not successful and ways to strengthen its effects. Published by Elsevier Inc.

Entities:  

Keywords:  Alcohol use disorder; Health care delivery; Implementation; Pharmacotherapy; Quality improvement

Mesh:

Year:  2017        PMID: 29021108     DOI: 10.1016/j.jsat.2017.09.002

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  15 in total

1.  Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders.

Authors:  Paul J Joudrey; Benjamin J Oldfield; Kimberly A Yonkers; Patrick G O'Connor; Gretchen Berland; E Jennifer Edelman
Journal:  Drug Alcohol Depend       Date:  2020-06-02       Impact factor: 4.492

2.  Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans.

Authors:  Kevin L Kraemer; Kathleen A McGinnis; David A Fiellin; Melissa Skanderson; Adam J Gordon; Jonathan Robbins; Susan Zickmund; Kendall Bryant; P Todd Korthuis
Journal:  J Subst Abuse Treat       Date:  2019-05-07

3.  Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs.

Authors:  Andrea K Finlay; Jessie J Wong; Laura S Ellerbe; Anna Rubinsky; Shalini Gupta; Thomas R Bowe; Eric M Schmidt; Christine Timko; Jennifer L Burden; Alex H S Harris
Journal:  J Stud Alcohol Drugs       Date:  2018-11       Impact factor: 2.582

4.  Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps.

Authors:  Jessica J Wyse; Adam J Gordon; Steven K Dobscha; Benjamin J Morasco; Elizabeth Tiffany; Karen Drexler; Friedhelm Sandbrink; Travis I Lovejoy
Journal:  Subst Abus       Date:  2018       Impact factor: 3.716

5.  Evaluation of an Implementation Intervention to Increase Reach of Evidence-Based Psychotherapies for PTSD in US Veterans Health Administration PTSD Clinics.

Authors:  Nina A Sayer; Nancy C Bernardy; Matthew Yoder; Jessica L Hamblen; Craig S Rosen; Princess E Ackland; Shannon M Kehle-Forbes; Barbara A Clothier; Paula P Schnurr; Robert J Orazem; Siamak Noorbaloochi
Journal:  Adm Policy Ment Health       Date:  2020-09-17

6.  Comorbid Substance Use Disorder Profiles and Receipt of Substance Use Disorder Treatment Services: A National Study.

Authors:  Curtis D Von Gunten; Li-Tzy Wu
Journal:  J Stud Alcohol Drugs       Date:  2021-03       Impact factor: 2.582

Review 7.  Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.

Authors:  Emily C Williams; Theresa E Matson; Alex H S Harris
Journal:  Addict Sci Clin Pract       Date:  2019-02-12

8.  Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes.

Authors:  Hildi J Hagedorn; Jennifer P Wisdom; Heather Gerould; Erika Pinsker; Randall Brown; Michael Dawes; Eric Dieperink; Donald Hugh Myrick; Elizabeth M Oliva; Todd H Wagner; Alex H S Harris
Journal:  Addict Sci Clin Pract       Date:  2019-07-10

9.  A systematic review of approaches to improve practice, detection and treatment of unhealthy alcohol use in primary health care: a role for continuous quality improvement.

Authors:  Monika Dzidowska; K S Kylie Lee; Claire Wylie; Jodie Bailie; Nikki Percival; James H Conigrave; Noel Hayman; Katherine M Conigrave
Journal:  BMC Fam Pract       Date:  2020-02-13       Impact factor: 2.497

10.  A Telemedicine Approach to Increase Treatment of Alcohol Use Disorder in Primary Care: A Pilot Feasibility Study.

Authors:  Amy Leibowitz; Derek D Satre; Wendy Lu; Constance Weisner; Caroline Corriveau; Elio Gizzi; Stacy Sterling
Journal:  J Addict Med       Date:  2021 Jan-Feb 01       Impact factor: 4.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.